Form 8-K Adverum Biotechnologies, For: Nov 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St set for higher open after Micron revives AI optimism, upbeat economic data
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
Adverum Biotechnologies (ADVM) PT Lowered to $10 at RBC Capital
November 5, 2024 6:57 AM ESTRBC Capital analyst Luca Issi lowered the price target on Adverum Biotechnologies (NASDAQ: ADVM) to $10.00 (from $12.00) while maintaining a Sector Perform rating.
The analyst comments "ADVM reported 3Q24 results and updated timelines for the next LUNA readout (52-week results now anticipated... More
